Fund 13F filing

Balyasny added $39.1M of Novo Nordisk A S (NVO) stock

SEC Form 13F · Filed Aug 14, 2026

Balyasny added $39.1M of Novo Nordisk A S (NVO) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 14, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

Novo Nordisk A S

Value

$39.1M

More NVO insider and Congress trades

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.